To test the hypothesis that cutaneous active vasodilation in heat stress is mediated by a redundant cholinergic cotransmitter system, we examined the effects of atropine on skin blood flow (SkBF) increases during heat stress in persons with (CF) and without cystic fibrosis (non-CF). Vasoactive intestinal peptide (VIP) has been implicated as a mediator of cutaneous vasodilation in heat stress. VIP-containing cutaneous neurons are sparse in CF, yet SkBF increases during heat stress are normal. In CF, augmented ACh release or muscarinic receptor sensitivity could compensate for decreased VIP; if so, active vasodilation would be attenuated by atropine in CF relative to non-CF. Atropine was administered into skin by iontophoresis in seven CF and seven matched non-CF subjects. SkBF was monitored by laser-Doppler flowmetry (LDF) at atropine treated and untreated sites. Blood pressure [mean arterial pressure (MAP)] was monitored (Finapres), and cutaneous vascular conductance was calculated (CVC = LDF/MAP). The protocol began with a normothermic period followed by a 3-min cold stress and 30-45 min of heat stress. Finally, LDF sites were warmed to 42 degrees C to effect maximal vasodilation. CVC was normalized to its site-specific maximum. During heat stress, CVC increased in both CF and non-CF (P < 0.01). CVC increases were attenuated by atropine in both groups (P < 0.01); however, the responses did not differ between groups (P = 0.99). We conclude that in CF there is not greater dependence on redundant cholinergic mechanisms for cutaneous active vasodilation than in non-CF.
Endothelin-1 (ET-1) is relevant to the pathogenesis of pulmonary arterial hypertension (PAH) in several species, including broiler chickens. In ET-1-induced vasoconstriction, L-type voltage-operated calcium channels (VOCCs) play a crucial role. In this study, the effect that ET-1 and the calcium channel blocker (CCB) nifedipine have on ET-1-induced vascular contraction in pulmonary artery rings of both, nonpulmonary hypertensive chickens (NPHC) and pulmonary hypertensive chickens (PHC), was evaluated. A significant increase response in ET-1 was observed for PHC vascular rings with respect to those of NPHC (p < .05). Incubation with 1 μM nifedipine did not completely reverse the contraction induced by 1 × 10 −7 M ET-1 in both NPHC and PHC rings, suggesting the participation of additional calcium sources procured via influx through L-type VOCC. Nifedipine reduced, to a higher degree, the contraction induced by ET-1 in NPHC (50%) when compared with that observed in PHC rings (30.7%). Thus, the ET-1-induced vasoconstriction processes are more efficient in PHC, and the influx of calcium into the cell through the L-type VOCC is presumably only a fraction of the necessary calcium for ET-1-induced vasoconstriction. It is suggested that blocking calcium uptake through alternative pathways (receptor-operated calcium channels and storage-operated calcium channels) may produce a vasodilation effect of considerable therapeutic significance in PHC.
ARTICLE HISTORY
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.